| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/30/2003 | EP1330271A2 Use of transcription factors for treating inflammation and other diseases |
| 07/30/2003 | EP1330270A2 Sustained release device for treating conditions of the joint |
| 07/30/2003 | EP1330262A1 Use of enzymes obtained from ciliates as medicaments for promoting digestion |
| 07/30/2003 | EP1330261A2 Treatment of hibernating myocardium and diabetic cardiomyopathy with a glp-1 peptide |
| 07/30/2003 | EP1330260A1 Use of il-1 inhibitors and tnf antagonists, partially in combination with recombinant erythropoietins, for the treatment of anemia |
| 07/30/2003 | EP1330259A2 Epitope-beta microglobulin polynucleotide for anti-cancer immunotherapy |
| 07/30/2003 | EP1330258A2 Kahalalide f formulation |
| 07/30/2003 | EP1330257A1 Gnrh analogues for treatment of urinary incontinence |
| 07/30/2003 | EP1330254A2 Treatment of cancers by aplidine in conjunction with a myoprotector |
| 07/30/2003 | EP1330252A1 In vivo stimulation of angiogenic activity |
| 07/30/2003 | EP1330240A2 Use of 20-hete synthesizing enzyme inhibitors as therapy for cerebral vascular diseases |
| 07/30/2003 | EP1330166A1 Food grade transglutaminase inhibitor and uses thereof |
| 07/30/2003 | EP1330156A1 Modulating cytokine or hormone signalling in an animal comprising up-regulating the expression of socs sequence in the animal |
| 07/30/2003 | EP1255534B1 Method for the preparation of microspheres which contain colloidal systems |
| 07/30/2003 | EP1165121B1 SUPAR STIMULATING ACTIVITY OF tcuPA-MEDIATED FIBRINOLYSIS AND DIFFERENT USES THEREOF |
| 07/30/2003 | EP1157037B1 Gcsf conjugates |
| 07/30/2003 | EP1039873A4 Keratin-based hydrogel for biomedical applications and method of production |
| 07/30/2003 | EP0981363B1 Somatostatin agonists for decreasing body weight |
| 07/30/2003 | EP0975362B1 Pharmaceutical or food composition for treating pathologies related to graft versus host, allergic or autoimmune reaction |
| 07/30/2003 | EP0956292A4 Conantokins |
| 07/30/2003 | EP0942780B1 Coated particles, methods of making and using |
| 07/30/2003 | EP0941067B1 Stable glassy state powder formulations |
| 07/30/2003 | EP0910400B1 Therapies for chronic renal failure |
| 07/30/2003 | EP0904062B1 Sustained release ionic conjugate |
| 07/30/2003 | EP0859628B1 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites |
| 07/30/2003 | EP0851926B1 Variants of human recombinant interferon-gamma (rhu-ifn-gamma) having increased heat-stability |
| 07/30/2003 | EP0832198B1 Oxygen activatable formulations for disinfection or sterilization |
| 07/30/2003 | EP0831936B1 Thiolation of peptides for radionuclide-based radiodetection and radiotherapy |
| 07/30/2003 | EP0831884B1 Use of bone morphogenic proteins for healing and repair of connective tissue attachment |
| 07/30/2003 | EP0785793B1 Allosteric modulators of the nmda receptor |
| 07/30/2003 | EP0748190B1 PROGESTOGEN-FREE FORMULATIONS OF GnRH AND ESTROGEN FOR TREATING BENIGN GYNECOLOGICAL DISORDERS |
| 07/30/2003 | EP0702696B1 Trifunctional antithrombin and antiplatelet peptides |
| 07/30/2003 | CN1433482A Method of testing remedy or preventive for hyperlipemia |
| 07/30/2003 | CN1433478A Novel colloid synthetic vectors for gene therapy |
| 07/30/2003 | CN1433477A Method of achieving persistent transgene expression |
| 07/30/2003 | CN1433471A 85Kgda neisserial antigen |
| 07/30/2003 | CN1433469A Therapeutically useful synthetic oligonucleotides |
| 07/30/2003 | CN1433466A MASP-3, complement-fixing enzyme, and uses for it |
| 07/30/2003 | CN1433429A Oligopeptides |
| 07/30/2003 | CN1433396A Pharmaceutical compounds |
| 07/30/2003 | CN1433325A Techniques and compositions for treating cardiovascular disease by in vivo gene delivery |
| 07/30/2003 | CN1433324A Interferon gamma conjugates |
| 07/30/2003 | CN1433320A Carbonyl stress-ameliorating agents |
| 07/30/2003 | CN1433319A Enzyme treatment for infection |
| 07/30/2003 | CN1433318A Vascular endothelial growth factor-2 |
| 07/30/2003 | CN1433317A Use of immunosuppessant for increasing antifungal activity of lipopetide |
| 07/30/2003 | CN1432652A Actinia neurotoxin gene and its application |
| 07/30/2003 | CN1432651A Actinia neurotoxin gene and its application |
| 07/30/2003 | CN1432650A Actinia neurotoxin gene and its application |
| 07/30/2003 | CN1432649A Actinia neurotoxin gene and its application |
| 07/30/2003 | CN1432647A Flat-chin sea snake long-chain neurotoxin gene and its expression and application |
| 07/30/2003 | CN1432577A Sheep growth hormone releasing hormone gene and its expression product and application |
| 07/30/2003 | CN1432406A Application of snake venom protein hydrolase in preparing medicine |
| 07/30/2003 | CN1116416C Blue green alga transgene by using gene intergration platform system and method for expressing thymosin al |
| 07/30/2003 | CN1116305C Peptide derivatives |
| 07/30/2003 | CN1116304C Organic compound |
| 07/30/2003 | CN1116282C Bisulfate salt of HIV protease inhibitor |
| 07/30/2003 | CN1116104C Method capable of scale preserving bioactivity matter by drying |
| 07/30/2003 | CN1116075C Medicine for treating male sterility and weak sperm disease |
| 07/30/2003 | CN1116074C Buccal lozenge for preventing dental caries and its production method |
| 07/30/2003 | CN1116030C Compositions for inhalation |
| 07/30/2003 | CA2369711A1 Macrocyclic peptides active against the hepatitis c virus |
| 07/29/2003 | US6600069 Insulin receptor kinase activators; treating hyperglycemia; 4-((3,5-bis(N-(4-sulfophenyl)carbamoyl)phenyl)carbonylamino)-benzenesulfonic acid, for example |
| 07/29/2003 | US6600030 Nucleotide sequences which code binding protein for use in diagnosis and treatment of asthma, arthritis, Crohn's and Grave's diseases and cystic fibrosis |
| 07/29/2003 | US6600027 Polynucleotide molecules encoding neospora proteins |
| 07/29/2003 | US6600024 Polypeptide for use in the treatment and prevention of cell proliferative disorders |
| 07/29/2003 | US6600022 Monoclonal antibody for use in treatment and preventon of autoimmune and allergic disease |
| 07/29/2003 | US6600021 Enzyme inhibitor for use in the preparation of dough and baked goods |
| 07/29/2003 | US6600020 Protein for use in the treatment of tumor and skin disorders in mammals; protein for use in veterinary medicine |
| 07/29/2003 | US6600019 Polypeptides and nucleic acids encoding same |
| 07/29/2003 | US6600018 Polypeptide for use in the treatment of tumors |
| 07/29/2003 | US6600017 Peptide for use in diagnosing alzheimer's disease |
| 07/29/2003 | US6600015 Treatment or prevention of obesity. |
| 07/29/2003 | US6600013 Moraxella catarrhalis BASB034 polypeptides and uses thereof |
| 07/29/2003 | US6600010 Biodegradable terephthalate polyester-poly (phosphate) polymers, compositions, articles, and methods for making and using the same |
| 07/29/2003 | US6599912 Methods and compositions for modulating cell proliferation and cell death |
| 07/29/2003 | US6599909 Transfection of tumor by an adenovirus encoding a cytosine deaminase gene, administering a dose of 5-fluorocytosine to said individual, treating said individual with a single or multiple fractions of radiation |
| 07/29/2003 | US6599894 Competitive inhibitors of trypsin-like proteases, such as thrombin, and in treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants |
| 07/29/2003 | US6599882 Secretin and secretin pharmaceuticals for treating lactose intolerance |
| 07/29/2003 | US6599881 Treating a thrombotic disorder that is not the result of an endotoxin-initiated coagulation cascade in a subject comprising administration of a bactericidal/ permeability-increasing protein (BPI) protein |
| 07/29/2003 | US6599880 Analog further comprises an amino acid substitution; for treating gram-negative bacterial infections in a subject |
| 07/29/2003 | US6599879 Therapeutic uses of keratinocyte growth factor-2 |
| 07/29/2003 | US6599878 For use in hemodilution, blood substitution, plasma expansion or fluid resuscitation; oxygen delivery |
| 07/29/2003 | US6599876 Medicament and method for treating renal disease |
| 07/29/2003 | US6599875 IL-6 antagonist peptides |
| 07/29/2003 | US6599874 Isolated from human milk for prophylactic and/or therapeutic treatment of infections caused by bacteria, in particular Streptococcus pneumoniae and Haemophilus influenzae in upper and lower airways, ear-nose-and-throat infections |
| 07/29/2003 | US6599873 Proteins are co-mitogens (with phytohemaglutinin) for T-cells, cause both fibroblasts and chondrocytes to secrete latent collagenase, and increase the surface adhesive powers of endothelial cells for neutrophils |
| 07/29/2003 | US6599742 Antisense oligonucleotide inhibition of human serine/threonine protein phosphatase gene expression |
| 07/29/2003 | US6599741 Modulating transcription of genes in vascular cells |
| 07/29/2003 | US6599739 Papillomavirus viral vector for use in the transfer of nucleotide sequences |
| 07/29/2003 | US6599728 Tankyrase II interacts with telomere-associated proteins, thereby affecting telomerase activity and potentially telomere length |
| 07/29/2003 | US6599727 Human poly (ADP-ribose) polymerase 2 materials and methods |
| 07/29/2003 | US6599726 Compositions and methods comprising cytostatic protein kinase |
| 07/29/2003 | US6599724 Pharmaceutical composition for use in the treatment of blood disorders |
| 07/29/2003 | US6599719 For therapy of rheumatoid arthritis, tumors |
| 07/29/2003 | US6599718 Growth hormone secretagogue related receptors and nucleic acids |
| 07/29/2003 | US6599710 Treatment of autoimmune disease |
| 07/29/2003 | US6599709 Method for screening for soluble ligands to a receptor-type tyrosine kinase |
| 07/29/2003 | US6599706 Recombinant PR-3 and assays employing the same |
| 07/29/2003 | US6599699 Methods for diagnosing a disorder by assaying for MAGE-3 |